Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Indivior Pharmaceuticals (INDV) Tax Provisions (2024 - 2025)

Indivior Pharmaceuticals (INDV) has 2 years of Tax Provisions data on record, last reported at -$22.0 million in Q4 2025.

  • For Q4 2025, Tax Provisions fell 229.41% year-over-year to -$22.0 million; the TTM value through Dec 2025 reached -$2.0 million, down 115.38%, while the annual FY2025 figure was $29.0 million, 163.64% up from the prior year.
  • Tax Provisions reached -$22.0 million in Q4 2025 per INDV's latest filing, down from -$5.0 million in the prior quarter.
  • Across five years, Tax Provisions topped out at $17.0 million in Q4 2024 and bottomed at -$23.0 million in Q2 2024.